针对非小细胞肺癌的向治疗的最新进展; 更新审查
Mahmood Araghi1, Reza Mannani2, Ali Heidarnejad Maleki3
1Department of Pathology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Cancer cell international
|August 11, 2023
概括
向治疗通过阻断瘤生长,为非小细胞肺癌 (NSCLC) 提供了成功的治疗结果. 这项研究全面审查了NSCLC瘤点和药物,包括临床试验.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 翻译研究是翻译研究.
背景情况:
- 肺癌仍然是全球癌症死亡的主要原因.
- 分子翻译研究在非小细胞肺癌 (NSCLC) 诊断和治疗方面取得了重大进展.
- 向治疗已经成为NSCLC的一种非常成功的治疗方法.
研究的目的:
- 在NSCLC中全面讨论瘤点抗原.
- 审查针对NSCLC治疗的向治疗药物.
- 总结目前对NSCLC患者的临床试验数据.
主要方法:
- 对NSCLC分子转化研究进展的审查.
- 针对性治疗机制的分析,包括基因和蛋白质对抗剂.
- 对NSCLC进行现有临床试验研究的汇编和摘要.
主要成果:
- 向治疗通过选择性地阻断瘤生长途径,证明了成功的结果.
- 了解瘤抗原和开发向药物的进展正在迅速发展NSCLC治疗.
- 临床试验提供了关于NSCLC向疗法的疗效和安全性的关键数据.
结论:
- 向治疗是现代NSCLC管理的基石,改善了患者的治疗结果和生活质量.
- 对瘤点和新型药物的持续研究对于推进NSCLC治疗至关重要.
- 整合临床试验结果对于优化NSCLC的向治疗策略至关重要.
更多相关视频
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.0K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
